[go: up one dir, main page]

NO993812L - (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler - Google Patents

(4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler

Info

Publication number
NO993812L
NO993812L NO993812A NO993812A NO993812L NO 993812 L NO993812 L NO 993812L NO 993812 A NO993812 A NO 993812A NO 993812 A NO993812 A NO 993812A NO 993812 L NO993812 L NO 993812L
Authority
NO
Norway
Prior art keywords
piperidinyl
derivatives useful
antipsychotic agents
antipsychotic
agents
Prior art date
Application number
NO993812A
Other languages
English (en)
Other versions
NO993812D0 (no
NO318936B1 (no
Inventor
Joseph Thomas Strupczewski
Kenneth J Bordeau
Shelley L Pavlek
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO993812D0 publication Critical patent/NO993812D0/no
Publication of NO993812L publication Critical patent/NO993812L/no
Publication of NO318936B1 publication Critical patent/NO318936B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO19993812A 1997-02-07 1999-08-06 (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler, farmasoytisk preparat inneholdende derivatene samt fremgangsmate for fremstilling derav. NO318936B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79710797A 1997-02-07 1997-02-07
PCT/US1998/000979 WO1998034933A1 (en) 1997-02-07 1998-01-20 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents

Publications (3)

Publication Number Publication Date
NO993812D0 NO993812D0 (no) 1999-08-06
NO993812L true NO993812L (no) 1999-10-05
NO318936B1 NO318936B1 (no) 2005-05-30

Family

ID=25169927

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993812A NO318936B1 (no) 1997-02-07 1999-08-06 (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler, farmasoytisk preparat inneholdende derivatene samt fremgangsmate for fremstilling derav.

Country Status (21)

Country Link
EP (1) EP1015446B1 (no)
JP (1) JP4177461B2 (no)
KR (1) KR100509878B1 (no)
CN (1) CN1092653C (no)
AR (1) AR011614A1 (no)
AT (1) ATE236150T1 (no)
AU (1) AU725301B2 (no)
BR (1) BRPI9807312B8 (no)
CA (1) CA2281702C (no)
CY (1) CY2324B1 (no)
DE (1) DE69812980T2 (no)
DK (1) DK1015446T3 (no)
ES (1) ES2194303T3 (no)
HU (1) HUP0001308A3 (no)
IL (1) IL131243A (no)
NO (1) NO318936B1 (no)
NZ (1) NZ336719A (no)
PT (1) PT1015446E (no)
TW (1) TW518333B (no)
WO (1) WO1998034933A1 (no)
ZA (1) ZA98831B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE459618T1 (de) 2004-04-29 2010-03-15 Aventis Pharma Inc 3-piperidinylisochroman-5-ole als dopaminagonisten
CN1993114B (zh) * 2004-05-28 2011-05-11 尤尼根制药公司 作为双核酶强效抑制剂的二芳基烷烃
KR101169518B1 (ko) 2007-07-26 2012-07-27 에프. 호프만-라 로슈 아게 5-ht2a 및 d3 수용체의 이중 조절제
CA2730265C (en) 2008-07-21 2016-06-28 Unigen, Inc. Series of skin-whitening (lightening) compounds
US8877778B2 (en) 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
CN102079720B (zh) * 2011-01-20 2013-02-06 蚌埠丰原医药科技发展有限公司 一种制备1-苄基-4-哌啶甲醛的方法
KR102113823B1 (ko) 2011-03-24 2020-05-21 유니젠, 인크. 디아릴프로판의 제조를 위한 화합물 및 방법
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
US4963568A (en) * 1989-05-31 1990-10-16 Abbott Laboratories Dopamine agonists

Also Published As

Publication number Publication date
AU725301B2 (en) 2000-10-12
BRPI9807312B8 (pt) 2016-09-13
HUP0001308A2 (hu) 2001-06-28
CA2281702C (en) 2006-04-11
JP4177461B2 (ja) 2008-11-05
CA2281702A1 (en) 1998-08-13
CY2324B1 (en) 2003-11-14
EP1015446B1 (en) 2003-04-02
HUP0001308A3 (en) 2001-07-30
BR9807312B1 (pt) 2013-10-29
NO993812D0 (no) 1999-08-06
BR9807312A (pt) 2000-05-02
AU5923798A (en) 1998-08-26
CN1246859A (zh) 2000-03-08
DE69812980T2 (de) 2003-11-13
DK1015446T3 (da) 2003-07-14
EP1015446A1 (en) 2000-07-05
JP2001512436A (ja) 2001-08-21
ATE236150T1 (de) 2003-04-15
DE69812980D1 (de) 2003-05-08
IL131243A (en) 2004-02-19
AR011614A1 (es) 2000-08-30
WO1998034933A1 (en) 1998-08-13
ZA98831B (en) 1998-08-07
KR100509878B1 (ko) 2005-08-25
TW518333B (en) 2003-01-21
ES2194303T3 (es) 2003-11-16
KR20000070862A (ko) 2000-11-25
CN1092653C (zh) 2002-10-16
NO318936B1 (no) 2005-05-30
PT1015446E (pt) 2003-08-29
NZ336719A (en) 2000-10-27
HK1027812A1 (en) 2001-01-23
IL131243A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
DK1930330T3 (da) Pleuromutilinderivater som antimikrobielle midler
NO20015365L (no) Piperidinderivater som er anvendbare som CCR5-antagonister
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
NO992725D0 (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
DE69817186D1 (de) Diaminorhodamin-derivate
DK0915088T3 (da) D-prolinderivater
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
DE50013404D1 (de) Substituierte 2-dialkylaminoalkylbiphenyl-derivate
ATE255098T1 (de) Substituierte chromanderivate
ATE440854T1 (de) 5-deoxy-cytidin-derivate
ATE255099T1 (de) Substituierte chromanderivate
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
NO993812L (no) (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler
DK0966437T3 (da) 5-Aroylnaphthalenderivater
DK1075471T3 (da) Idolylderivater som serotonerge midler
TR200002831A3 (tr) Kinolin-4-Il türevleri I
NO20000434D0 (no) Lyksofuranosyl benzimidazoler som antivirale midler
ATE292632T1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
DK1196403T3 (da) Antipsykotiske N-aralkylaminer
DK1073651T3 (da) Indolylderivater som serotonerge midler
NO972905D0 (no) Tienoksasinon-derivater anvendelige som antivirusmidler